ZBH Stock Recent News

WARSAW, Ind. , May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, Global Businesses and the Americas.

WARSAW, Ind., May 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025, at 9:20 a.m.

Ivan Tornos, Zimmer Biomet CEO, joins 'Closing Bell Overtime' from the CNBC CEO Council Summit to talk navigating a changing political landscape, partnering with Arnold Schwarzenegger and more.

If there is one voice on Wall Street that we always listen to, it is Stifel's Barry Bannister, and with good reason.

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

Zimmer Biomet Holdings, Inc ZBH reported better-than-expected earnings for the first quarter on Monday.

Live Updates Live Coverage Has Ended Markets Pivot to Ford Earnings 4:03 pm by Gerelyn Terzo The markets failed to turn around, ending the trading session lower across the board and ending a multi-session winning streak. Stocks are awaiting further details on trade deals, which the White House has revealed could come as soon as this week, which would not be soon enough for the markets. Ford (NYSE: F) stock fell just over 1% on the day ahead of the automaker’s quarterly results after the closing bell today. When fellow automaker General Motors (NYSE: GM) reported its quarterly results last month, the company withdrew its profit guidance due to tariff uncertainty. Here’s how the major indices finished the trading day: Dow Jones Industrial Average: Down 69.52 (-0.17%) Nasdaq Composite: Down 132.40 (-0.74%) S&P 500: Down 36.79 (-0.66%) Economic Uncertainty 12:32 pm by Gerelyn Terzo U.S. Treasury Secretary Scott Bessent is making the rounds, speaking to global investors toda

Zimmer Biomet's stock dropped nearly 10% on the back of soft Q1 results. Despite structural tailwinds, Zimmer Biomet's business is struggling in the face of high interest rates, trade tensions and competition. Zimmer Biomet's cash flows appear set to be particularly hard hit by tariffs, meaning the company's share price is likely to remain depressed until this is resolved.

Zimmer Biomet Holdings, Inc ZBH reported first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77.

Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.